Skip to main content
SpringerLink
Log in

Psychological Effects of Device Recalls and Advisories in Patients with Implantable Cardioverter Defibrillators

  • Chapter
  • First Online:
Psychological, Emotional, Social and Cognitive Aspects of Implantable Cardiac Devices

  • 504 Accesses

Abstract

Implantable cardioverter defibrillators (ICD) are subject to technical failures. The current chapter reviews the impact of the resulting public advisories on patient psychological welfare and quality of life.

Despite the paucity of research on the impact of ICD advisories, available data suggest that ICD advisories, involving either possible generator or lead malfunction, result in limited long-term adverse psychosocial effects in most patients. This appears particularly true in patients followed in supportive device clinics where provision of prompt information, counselling, and reassurance is provided by healthcare professionals. Individuals dependent on the ICD for pacing or requiring more intensive interventions (such as device replacement) following the advisory may be more vulnerable to increased distress, as may patients who have experienced inappropriate shocks. Additional counselling or psychological support in these patients may be required.

As research to date has relied mostly on small single-center observational ad hoc studies, more reliable information is required to confirm these impressions. Ideally, patient-reported outcomes would need to be routinely and repeatedly assessed and included within national registries.

Moreover, research on the psychosocial impact of advisories is consistent with other research in ICD patients, showing significant impairments in QoL and psychological status in many patients that persist for years, independently of advisories. The psychosocial experiences of many patients are not adequately attended to, and this may contribute to a worse prognosis.

Information gleaned from research on this issue could facilitate physician-patient decision-making and lead to improved psychological support for patients whose devices are under advisory as well as those considering ICD therapy for the first time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071–8.

    Article  CAS  PubMed  Google Scholar 

  2. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44:2166–72.

    Article  PubMed  Google Scholar 

  3. Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant FC, Tu JV, Alter DA. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol. 2003;41:1573–82.

    Article  PubMed  Google Scholar 

  4. De Ornelas Maia AC, Soares-Filho G, Pereira V, Nardi AE, Silva AC. Psychiatric disorders and quality of life in patients with implantable cardioverter defibrillators: a systematic review. Prim Care Companion CNS Disord. 2013;15

    Google Scholar 

  5. Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB, Mcdaniel G, Pressler SJ, Schron E, Wang P, Zeigler VL, American Heart Association Council on Cardiovascular Nursing, C. O. C. C. and Council on Cardiovascular Disease in the Yong. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation. 2012;126:2146–72.

    Article  PubMed  Google Scholar 

  6. Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl EA, Singh PP, Barroso MMB, Arthurs E, Roseman M, Amin N, Marine JE, Ziegelstein RC. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res. 2011;71:223–31.

    Article  PubMed  Google Scholar 

  7. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474–80.

    Article  PubMed  Google Scholar 

  8. Maisel WH. Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA. 2005;294:2040–2.

    Google Scholar 

  9. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB, Schultz DB. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295:1901–6.

    Article  CAS  PubMed  Google Scholar 

  10. Vlay SC. Concerns about the Riata ST (St. Jude Medical) ICD lead. Pacing Clin Electrophysiol. 2008;31:1–2.

    Article  PubMed  Google Scholar 

  11. Sengupta J, Kendig AC, Goormastic M, Hwang ES, Ching EA, Chung R, Lindsay BD, Tchou PJ, Wilkoff BL, Niebauer MJ, Martin DO, Varma N, Wazni O, Saliba W, Kanj M, Bhargava M, Dresing T, Taigen T, Ingelmo C, Bassiouny M, Cronin EM, Wilsmore B, Rickard J, Chung MK. Implantable cardioverter-defibrillator FDA safety advisories: impact on patient mortality and morbidity. Heart Rhythm. 2012;9:1619–26.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295:1907–11.

    Article  CAS  PubMed  Google Scholar 

  13. Morrison TB, Friedman PA, Kallinen LM, Hodge DO, Crusan D, Kumar K, Hayes DL, Rea RF, Hauser RG. Impact of implanted recalled Sprint Fidelis lead on patient mortality. J Am Coll Cardiol. 2011;58:278–83.

    Article  PubMed  Google Scholar 

  14. Hegel MT, Griegel LE, Black C, Goulden L, Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. Int J Psychiatry Med. 1997;27:57–69.

    Article  CAS  PubMed  Google Scholar 

  15. Pedersen SS, Van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005;149:664–9.

    Article  PubMed  Google Scholar 

  16. Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, Thibault B, Connors S, Healey JS, Champagne J, Cameron D, Mangat I, Verma A, Wolfe K, Essebag V, Kus T, Ayala-Paredes F, Davies T, Sanatani S, Gow R, Coutu B, Sivakumaran S, Stephenson E, Krahn A. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation. 2010;121:2384–7.

    Article  PubMed  Google Scholar 

  17. El-Chami MF, Merchant FM, Levy M, Alam MB, Rattan R, Hoskins MH, Langberg JJ, Delurgio D, Lloyd MS, Leon AR, Saba S. Outcomes of Sprint Fidelis and Riata lead extraction: data from 2 high-volume centers. Heart Rhythm. 2015;12:1216–20.

    Article  PubMed  Google Scholar 

  18. Gibson DP, Kuntz KK, Levenson JL, Ellenbogen KA. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace. 2008;10:540–4.

    Article  PubMed  Google Scholar 

  19. Cuculi F, Herzig W, Kobza R, Erne P. Psychological distress in patients with ICD recall. Pacing Clin Electrophysiol. 2006;29:1261–5.

    Article  PubMed  Google Scholar 

  20. Undavia M, Goldstein NE, Cohen P, Sinthawanarong K, Singson M, Bhutani D, Munson T, Gomes JA, Fischer A, Mehta D. Impact of implantable cardioverter-defibrillator recalls on patients’ anxiety, depression, and quality of life. Pacing Clin Electrophysiol. 2008;31:1411–8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Keren A, Sears SF, Nery P, Shaw J, Green MS, Lemery R, Gollob MH, Amyotte B, Birnie DH. Psychological adjustment in ICD patients living with advisory Fidelis leads. J Cardiovasc Electrophysiol. 2011;22:57–63.

    Article  PubMed  Google Scholar 

  22. Birnie DH, Sears SF, Green MS, Lemery R, Gollob MH, Amyotte B. No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience. Europace. 2009;11:26–30.

    Article  PubMed  Google Scholar 

  23. D'Antono B, Goldfarb M, Solomon C, Sturmer M, Becker G, Essebag V, Hadjis T, Gizicki E, Gelais JS, Sas G, Cote MC, Kus T. Psychological impact of surveillance in patients with a defibrillator lead under advisory: a prospective evaluation. Pacing Clin Electrophysiol. 2013;36:221–30.

    Article  PubMed  Google Scholar 

  24. Sneed NV, Finch NJ, Leman RB. The impact of device recall on patients and family members of patients with automatic implantable cardioverter-defibrillators. Heart Lung. 1994;23:317–22.

    CAS  PubMed  Google Scholar 

  25. Van Den Broek KC, Denollet J, Nyklicek I, Van Der Voort PH. Psychological reaction to potential malfunctioning of implantable defibrillators. Pacing Clin Electrophysiol. 2006;29:953–6.

    Article  PubMed  Google Scholar 

  26. Heatherly SJ, Simmons T, Fitzgerald DM, Mitchell M. Psychological effects of implantable cardioverter-defibrillator leads under advisory. Pacing Clin Electrophysiol. 2011;34:694–9.

    Article  PubMed  Google Scholar 

  27. Pedersen SS, Versteeg H, Nielsen JC, Mortensen PT, Johansen JB. Patient-reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification. Europace. 2011;13:1292–8.

    Article  PubMed  Google Scholar 

  28. Larsen JM, Riahi S, Johansen JB, Nielsen JC, Petersen HH, Haarbo J, Pedersen SS. The patient perspective on the Riata defibrillator lead advisory: a Danish nationwide study. Heart Rhythm. 2014;11:2148–55.

    Article  PubMed  Google Scholar 

  29. Fisher JD, Koulogiannis KP, Lewallen L, Katz D, Kim SG, Ferrick KJ, Gross JN, Krumerman AK, Johnston DR, Mercaldi BC. The psychological impact of implantable cardioverter-defibrillator recalls and the durable positive effects of counseling. Pacing Clin Electrophysiol. 2009;32:1012–6.

    Article  PubMed  Google Scholar 

  30. Stutts LA, Conti JB, Aranda JM Jr, Miles WM, Burkart TA, Sears SF. Patient evaluation of ICD recall communication strategies: a vignette study. Pacing Clin Electrophysiol. 2007;30:1105–11.

    Article  PubMed  Google Scholar 

  31. Shaw RE, Cohen F, Doyle B, Palesky J. The impact of denial and repressive style on information gain and rehabilitation outcomes in myocardial infarction patients. Psychosom Med. 1985;47:262–73.

    Article  CAS  PubMed  Google Scholar 

  32. Kallinen LM, Hauser RG, Lee KW, Almquist AK, Katsiyiannis WT, Tang CY, Melby DP, Gornick CC. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2008;5:775–9.

    Article  PubMed  Google Scholar 

  33. Ha JF, Longnecker N. Doctor-patient communication: a review. Ochsner J. 2010;10:38–43.

    PubMed  PubMed Central  Google Scholar 

  34. Molloy GJ, Perkins-Porras L, Strike PC, Steptoe A. Social networks and partner stress as predictors of adherence to medication, rehabilitation attendance, and quality of life following acute coronary syndrome. Health Psychol. 2008;27:52–8.

    Article  PubMed  Google Scholar 

  35. Broadbent E, Ellis CJ, Thomas J, Gamble G, Petrie KJ. Can an illness perception intervention reduce illness anxiety in spouses of myocardial infarction patients? A randomized controlled trial. J Psychosom Res. 2009;67:11–5.

    Article  PubMed  Google Scholar 

  36. Kaplan RM, Toshima MT. The functional effects of social relationships on chronic illnesses and disability. In: Sarason BR, Sarason IG, Pierce GR, editors. Social support: an interactional view. New York: Wiley; 1990.

    Google Scholar 

  37. Krantz DS, Deckel AW. Coping with coronary heart disease and stroke. In: Burish TG, Bradley LA, editors. Coping with chronic disease: research and applications. NewYork: Academic; 1983.

    Google Scholar 

  38. Lett HS, Blumenthal JA, Babyak MA, Strauman TJ, Robins C, Sherwood A. Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med. 2005;67:869–78.

    Article  PubMed  Google Scholar 

  39. Suzuki T, Shiga T, Kuwahara K, Kobayashi S, Suzuki S, Nishimura K, Suzuki A, Ejima K, Manaka T, Shoda M, Ishigooka J, Kasanuki H, Hagiwara N. Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study. Pacing Clin Electrophysiol. 2010;33:1455–61.

    Article  PubMed  Google Scholar 

  40. Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry. 2008;65:1324–30.

    Article  PubMed  Google Scholar 

  41. Pedersen SS, Van Den Broek KC, Erdman RAM, Jordaens L, Theuns D. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace. 2010;12:1446–52.

    Article  PubMed  Google Scholar 

  42. Celano CM, Huffman JC. Depression and cardiac disease a review. Cardiol Rev. 2011;19:130–42.

    Article  PubMed  Google Scholar 

  43. Mcgrady A, Mcginnis R, Badenhop D, Bentle M, Rajput M. Effects of depression and anxiety on adherence to cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2009;29:358–64.

    Article  PubMed  Google Scholar 

  44. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure—a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–37.

    Article  PubMed  Google Scholar 

  45. Shen BJ, Eisenberg SA, Maeda U, Farrell KA, Schwarz ER, Penedo FJ, Bauerlein EJ, Mallon S. Depression and anxiety predict decline in physical health functioning in patients with heart failure. Ann Behav Med. 2011;41:373–82.

    Article  PubMed  Google Scholar 

  46. Meijer A, Conradi HJ, Bos EH, Thombs BD, Van Melle KP, De Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33:203–16.

    Article  PubMed  Google Scholar 

  47. Roest AM, Martens EJ, Denollet J, De Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010;72:563–9.

    Article  PubMed  Google Scholar 

  48. Van Melle JP, De Jonge P, Spijkerman TA, Tijssen JGP, Ormel J, Van Veldhuisen DJ, Van Den Brink RHS, Van Den Berg MP. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814–22.

    Article  PubMed  Google Scholar 

  49. Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med. 2004;66:898–902.

    Article  PubMed  Google Scholar 

  50. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety. 1999;9:163–8.

    Article  CAS  PubMed  Google Scholar 

  51. Whang W, Albert CM, Sears SF Jr, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA, Investigators TS. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol. 2005;45:1090–5.

    Article  PubMed  Google Scholar 

  52. Mastenbroek MH, Versteeg H, Jordaens L, Theuns DA, Pedersen SS. Ventricular tachyarrhythmias and mortality in patients with an implantable cardioverter defibrillator: impact of depression in the MIDAS cohort. Psychosom Med. 2014;76:58–65.

    Article  PubMed  Google Scholar 

  53. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818–23.

    Article  CAS  PubMed  Google Scholar 

  54. Chevalier P, Cottraux J, Mollard E, Sai N, Brun S, Burri H, Restier L, Adeleine P. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J. 2006;151:191.

    Article  PubMed  Google Scholar 

  55. Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, Curtis AB, Conti JB. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol. 2000;23:939–45.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, QC H1T 1C8, Canada

    Bianca D’Antono Ph.D. & Audrey Charneux M.A.

  2. Department of Psychology, Université de Montréal, Montreal, QC, Canada

    Bianca D’Antono Ph.D.

  3. Cardiology Department, Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada

    Teresa Kus M.D., Ph.D.

  4. Pharmacology and Physiology Department, Université de Montréal, Montreal, QC, Canada

    Teresa Kus M.D., Ph.D.

Authors
  1. Bianca D’Antono Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa Kus M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Audrey Charneux M.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bianca D’Antono Ph.D. .

Editor information

Editors and Affiliations

  1. Cardiac Center, Morriston Hospital, University of Swansea, Swansea, United Kingdom

    Riccardo Proietti

  2. eCampus University Faculty of Psychology, Novedrate (Como), Italy

    Gian Mauro Manzoni

  3. Department of Psychology, Università Cattolica del Sacro Cuore, Milano, Italy

    Giada Pietrabissa

  4. Department of Psychology, Università Cattolica del Sacro Cuore, Milano, Italy

    Gianluca Castelnuovo

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

D’Antono, B., Kus, T., Charneux, A. (2017). Psychological Effects of Device Recalls and Advisories in Patients with Implantable Cardioverter Defibrillators. In: Proietti, R., Manzoni, G., Pietrabissa, G., Castelnuovo, G. (eds) Psychological, Emotional, Social and Cognitive Aspects of Implantable Cardiac Devices. Springer, Cham. https://doi.org/10.1007/978-3-319-55721-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55721-2_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55719-9

  • Online ISBN: 978-3-319-55721-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation